These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2171318)
1. Phase I study of acivicin and cisplatin in non-small-cell lung cancer. A National Cancer Institute of Canada study. Maroun JA; Stewart DJ; Verma S; Evans WK; Eisenhauer E Am J Clin Oncol; 1990 Oct; 13(5):401-4. PubMed ID: 2171318 [TBL] [Abstract][Full Text] [Related]
2. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154 [TBL] [Abstract][Full Text] [Related]
3. [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer]. Li JL; Zhang XR; Liu JW; Chen ZY; Lin YC; Wang YD; Chen Q; Nan KJ; Song SP; Han FC; Zhu YZ; Li LY; Zheng YH; Chu DT Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):309-12. PubMed ID: 16875636 [TBL] [Abstract][Full Text] [Related]
4. Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer. An Eastern Cooperative Oncology Group study. Bonomi P; Finkelstein D; Chang A Am J Clin Oncol; 1994 Jun; 17(3):215-7. PubMed ID: 8192104 [TBL] [Abstract][Full Text] [Related]
5. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173 [TBL] [Abstract][Full Text] [Related]
6. A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study. Graziano SL; Herndon JE; Richards F; DiFino S; Modeas C; Duggan DB; Green MR Cancer; 1993 Jul; 72(1):62-8. PubMed ID: 8389667 [TBL] [Abstract][Full Text] [Related]
7. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772 [TBL] [Abstract][Full Text] [Related]
8. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results. Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967 [TBL] [Abstract][Full Text] [Related]
9. A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer. Hotta K; Sekine I; Tamura T; Sawada M; Watanabe H; Kusaba H; Akiyama Y; Inoue A; Shimoyama T; Nokihara H; Ueda Y; Yamamoto N; Kunitoh H; Ohe Y; Kodama T; Saijo N Jpn J Clin Oncol; 2001 Dec; 31(12):596-600. PubMed ID: 11902490 [TBL] [Abstract][Full Text] [Related]
10. Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer. Shinkai T; Arioka H; Kunikane H; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Oshita F; Nishio M; Karato A Cancer Res; 1994 May; 54(10):2636-42. PubMed ID: 8168091 [TBL] [Abstract][Full Text] [Related]
11. Phase II study of acivicin in non-small cell lung cancer: a National Cancer Institute of Canada Study. Maroun JA; Maksymiuk A; Eisenhauer E; Stewart DJ; Young V; Pater J Cancer Treat Rep; 1986 Nov; 70(11):1327-8. PubMed ID: 3021326 [TBL] [Abstract][Full Text] [Related]
12. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490 [TBL] [Abstract][Full Text] [Related]
13. Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer. Millward MJ; Zalcberg J; Bishop JF; Webster LK; Zimet A; Rischin D; Toner GC; Laird J; Cosolo W; Urch M; Bruno R; Loret C; James R; Blanc C J Clin Oncol; 1997 Feb; 15(2):750-8. PubMed ID: 9053501 [TBL] [Abstract][Full Text] [Related]
14. Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group. Font A; Moyano AJ; Puerto JM; Tres A; Garcia-Giron C; Barneto I; Anton A; Sanchez JJ; Salvador A; Rosell R Cancer; 1999 Feb; 85(4):855-63. PubMed ID: 10091762 [TBL] [Abstract][Full Text] [Related]
15. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230 [TBL] [Abstract][Full Text] [Related]
16. Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer. Shepherd FA; Evans WK; Goss PE; Latreille J; Logan D; Maroun J; Stewart D; Warner E; Paul K Semin Oncol; 1992 Feb; 19(1 Suppl 1):54-8. PubMed ID: 1329213 [TBL] [Abstract][Full Text] [Related]
17. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer. Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753 [TBL] [Abstract][Full Text] [Related]
18. Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study. Miller AA; Hargis JB; Lilenbaum RC; Fields SZ; Rosner GL; Schilsky RL J Clin Oncol; 1994 Dec; 12(12):2743-50. PubMed ID: 7527456 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma. Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186 [TBL] [Abstract][Full Text] [Related]
20. Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen. A phase II study. Tummarello D; Graziano F; Isidori P; Santo A; Cetto G; Fedeli A; Rossi G; Cellerino R Cancer; 1996 Jun; 77(11):2251-7. PubMed ID: 8635092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]